SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-327138
Filing Date
2017-10-31
Accepted
2017-10-31 16:03:57
Documents
49
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d460351d10q.htm 10-Q 338954
2 EX-31.1 d460351dex311.htm EX-31.1 6282
3 EX-31.2 d460351dex312.htm EX-31.2 6193
4 EX-32.1 d460351dex321.htm EX-32.1 2702
5 EX-32.2 d460351dex322.htm EX-32.2 2675
  Complete submission text file 0001193125-17-327138.txt   2397649

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ogen-20170930.xml EX-101.INS 289882
7 XBRL TAXONOMY EXTENSION SCHEMA ogen-20170930.xsd EX-101.SCH 37924
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ogen-20170930_cal.xml EX-101.CAL 40083
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ogen-20170930_def.xml EX-101.DEF 132829
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ogen-20170930_lab.xml EX-101.LAB 303502
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ogen-20170930_pre.xml EX-101.PRE 212517
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

IRS No.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32188 | Film No.: 171165735
SIC: 2834 Pharmaceutical Preparations